Clindamycin

Molecular formula: C31H39D7O2Molecular weight: 457.74

Lornoxicam (chlortenoxicam) is a new nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic, anti-inflammatory and antipyretic properties. 

Labeled Olopatadine, intended for use as an internal standard for the quantification of Olopatadine by GC- or LC-mass spectrometry.

Simethicone is a poly(dimethylsiloxane) which is a polymer of 200-350 units of dimethylsiloxane, along with added silica gel. It is used as an antiflatulent, surfactant, and ointment base.

Multiple kinase inhibitor targeting both RAF kinase and receptor tyrosine kinases that promote angiogensis. Antineoplastic.

Labeled Tetrabenazine, intended for use as an internal standard for the quantification of Tetrabenazine by GC- or LC-mass spectrometry.

Labelled Clobetasol. Topical corticosteroid. Glucocorticoid; anti-inflammatory.;Labeled Clobetasol, intended for use as an internal standard for the quantification of Clobetasol by GC- or LC-mass spectrometry.

A supplementary drug that improves the coccidiostatic effect of nicarbazin and amprolium in order to cure coccidiosis in chickens.

An immunosuppressant macrolide antibiotic and an inhibitor of FRAP.

Methylcellulose is used as a preservative, thickener and emulsifier in various food and cosmetic substances.

Labeled Clindamycin, intended for use as an internal standard for the quantification of Clindamycin by GC- or LC-mass spectrometry.

Labeled Clopidogrel, intended for use as an internal standard for the quantification of Clopidogrel by GC- or LC-mass spectrometry.

Clearsynth Labs Limited is a technology-based, research-driven, innovation-led enterprise specializing in deuterium chemistry and stable isotopes. Headquartered in Mumbai, with an R&D center in Hyderabad and a CDMO facility in Karnataka, alongside operations in Canada and the USA, we deliver solutions from milligram-scale R&D to multi-ton manufacturing. Our expertise spans deuterated APIs, intermediates, impurities, and reference standards. Backed by strong IP and 350+ scientists, we partner with innovators and generics across CDMO and CMO segments, committed to precision, quality, and advancing next-generation isotopic solutions for global pharmaceutical needs.